ER-Negative PR-Negative HER2-Negative Breast Cancer
3 clinical trials · Condition
◉ Watch ER-Negative PR-Negative HER2-Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC (NCT03361800) | UNC Lineberger Comprehensive Cancer Center | 2018-11-28 |
| A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer (NCT02685306) | Peregrine Pharmaceuticals | 2016-03-01 |
| Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC (NCT02531425) | OncoSec Medical Incorporated | 2015-09-01 |
Track ER-Negative PR-Negative HER2-Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.